Group 1 - The company Kintor Pharmaceutical (02171) has updated its share buyback plan to repurchase up to 25,461,295 shares within 50 trading days starting from November 13, 2025 [1] - The updated buyback plan represents 5% of the total issued shares as of the authorization date in 2025, including shares already repurchased in 2025 [1] - The board believes that the current share price is below its true value and does not adequately reflect the company's business prospects, indicating confidence in long-term growth and market performance [1] Group 2 - The board has been informed that Eucure Biopharma and its concert parties have cumulatively purchased 100,000 shares between November 6 and November 10, 2025 [1] - Following this acquisition, Eucure and its concert parties hold a total of 218,048,730 shares, representing approximately 37.92% of the total issued shares as of the announcement date, excluding treasury shares [1]
科济药业-B(02171)拟回购最多约2546.13万股股份 获主要股东增持10万股股份